# Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina

> **NCT00225342** · PHASE4 · WITHDRAWN · sponsor: **University of Glasgow** · enrollment: 60 (—)

## Conditions studied

- Angina Pectoris
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Rosiglitazone
- **DRUG:** Gliclazide (Comparison drug)

## Key facts

- **NCT ID:** NCT00225342
- **Lead sponsor:** University of Glasgow
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00225342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00225342, "Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00225342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*